This protocol addresses a severe presentation in which muscle spasms and stiffness become continuous across the thoracolumbar, thoracocervical, sternal, and laryngopharyngeal muscles — a state termed status spasticus. The clinical picture includes breathing difficulties, tremulous voice, hyperhidrosis, and tachycardia, reflecting widespread neuromuscular involvement that distinguishes this from milder episodic flares.
Involvement of respiratory and laryngopharyngeal musculature produces breathing difficulties and impaired verbalisation. Concurrent autonomic features — tachycardia and hyperhidrosis — underscore the severity of this exacerbation and typically necessitate urgent, targeted intervention.
Management of status spasticus involves a specific parenteral approach for severe, prolonged spasms, with an additional short-term adjunct strategy available for acute exacerbations. The clinical goal is resolution of the continuous muscle spasms and stiffness. The complete agent selection, sequencing, and adjunct protocol is available in the full regimen.
In severe cases, the spasms and stiffness in the thoracolumbar, thoracocervical, sternal, and laryngopharyngeal muscles become continuous causing breathing difficulties, tremulous voice with difficulty verbalizing, hyperhidrosis, and tachycardia, a condition we have called "status spasticus" that often requires intervention with IV diazepam.
Diazepam is especially effective in status spasticus, preferably given IV in severe and long-lasting spasms or in a rectal form.
Plasmapheresis: As an adjunct short-term therapy for exacerbations of severe spasms.
View source ↗